To include your compound in the COVID-19 Resource Center, submit it here.

Neovastat (AE-941): Began Phase II trial

Aeterna Laboratories Inc. (TSE:AEL; AELA), Quebec City, Quebec
Product: Neovastat (AE-941)

Read the full 111 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE